{"nct_id":"NCT00603668","title":"Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL","status":"COMPLETED","status_verified_date":"2013-03","start_date":"2008-08","start_date_type":null,"primary_completion_date":"2013-01","primary_completion_date_type":"ACTUAL","completion_date":"2013-02","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}